Controlled study for evaluation of the effect of AHCC(R) intake on eradication of high-risk type Human papillomavirus infectio
Not Applicable
Recruiting
- Conditions
- High-risk type Human papillomavirus (HPV) infection
- Registration Number
- JPRN-UMIN000036062
- Lead Sponsor
- Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 180
Inclusion Criteria
Not provided
Exclusion Criteria
(a) Women diagnosed as having a histological diagnosis of Cervical Intraepithelial Neoplasia (CIN) grade 3 or worse, or who are in need of medical treatment (b) Women taking immuno suppressors such as steroids or biologics such as TNF-alpha (c) Women regularly taking immunostimulating supplements (d) Women with an uncontrolled progressive malignancy (e) Women suffering from any mental illness or mental symptoms which would make it difficult for them to participate in the study (f) Women who are unable to return for follow-up appointments. (g) Women who are or may be pregnant (h) Women who, for any other reason, are considered not suitable for participation by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Persistent high-risk HPV infection
- Secondary Outcome Measures
Name Time Method